Anticholinergic burden and behavioral and psychological symptoms in older patients with cognitive impairment
In conclusion, the anticholinergic burden might play a significant role as a risk factor for developing more severe BPSD in patients with cognitive decline, independently from their degree of cognitive impairment.
Authors
- Sabrina Pistorio
- María Isabel Vargas (ORCID: https://orcid.org/0000-0002-6571-5336)
- Paola Iacotucci (ORCID: https://orcid.org/0000-0002-8909-9726)
- Leonardo Bencivenga (ORCID: https://orcid.org/0000-0002-9575-8337)
- Mauro Cataldi (ORCID: https://orcid.org/0000-0001-7787-3406)
- Grazia Daniela Femminella (ORCID: https://orcid.org/0000-0002-7397-483X)
- Michela Zanetti (ORCID: https://orcid.org/0000-0002-2634-6363)
- Vincenzo Carnovale (ORCID: https://orcid.org/0000-0002-4246-6883)
- Raffaella Merenda
- Gianluigi Cuomo
- Annalaura Manes
- Gianluca Scotto Di Tella
- Giuseppe Rengo
- Vittoria Canzanella
Institutions
- University of Trieste (IT)
- Istituti Clinici Scientifici Maugeri (IT)
- Imperial College London (GB)
- University of Naples Federico II (IT)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-02-12
- DOI
- https://doi.org/10.3389/fmed.2025.1505007
- Citations
- 8
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 11.77
Funders
- Università degli Studi di Napoli Federico II